Neurotherapeutics : Impact Factor & More
eISSN: 1878-7479pISSN: 1933-7213
Share this on:
Key Metrics
CiteScore 
10
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Pharmacology
SNIP
1.75
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Neurotherapeutics
Neurotherapeutics Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2004 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Neurotherapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Neurotherapeutics
Current and emerging therapies in IDH-mutant glioma.
- 1 Oct 2026
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Focused ultrasound in epilepsy.
- 8 Aug 2026
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
NAcLat-DBS reduces GABAB expression of dopamine neurons to correct depressive symptoms in CMS mice.
- 7 Aug 2026
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
NTI164, a novel medicinal cannabis extract, improves core symptoms of autism spectrum disorder: Results from a double-blind, randomised, controlled trial (The Harmony study).
- 6 Aug 2026
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Intrabody B1 targeting TDP-43 modulates neuroinflammatory and metabolic pathways in a preclinical ALS model.
- 6 Aug 2026
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Extracellular vesicles: Navigating new frontiers in glioblastoma therapy.
- 6 Aug 2026
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Current and emerging therapies in IDH-mutant glioma.
- 1 Oct 2026
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Focused ultrasound in epilepsy.
- 8 Aug 2026
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
NAcLat-DBS reduces GABAB expression of dopamine neurons to correct depressive symptoms in CMS mice.
- 7 Aug 2026
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
NTI164, a novel medicinal cannabis extract, improves core symptoms of autism spectrum disorder: Results from a double-blind, randomised, controlled trial (The Harmony study).
- 6 Aug 2026
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Intrabody B1 targeting TDP-43 modulates neuroinflammatory and metabolic pathways in a preclinical ALS model.
- 6 Aug 2026
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Extracellular vesicles: Navigating new frontiers in glioblastoma therapy.
- 6 Aug 2026
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
FAQs on Neurotherapeutics
How long has Neurotherapeutics been actively publishing? 
What is the publishing frequency of Neurotherapeutics?
How many articles did Neurotherapeutics publish last year?
What is the eISSN & pISSN for Neurotherapeutics?
What is Citescore for Neurotherapeutics?
What is SNIP score for Neurotherapeutics?
What is the SJR for Neurotherapeutics?
Who is the publisher of Neurotherapeutics?
